Ignite Creation Date:
2024-05-05 @ 11:07 PM
Last Modification Date:
2024-10-26 @ 10:29 AM
Study NCT ID:
NCT01264224
Status:
COMPLETED
Last Update Posted:
2014-01-22
First Post:
2010-12-20
Brief Title:
PAC-14028 in Healthy Male Volunteers
Sponsor:
Amorepacific Corporation
Organization:
Amorepacific Corporation
Study Overview
Official Title:
A Dose-block Randomized Double-blind Placebo-controlled SingleMultiple Dosing Dose-escalation Phase I Clinical Trial to Investigate the SafetyTolerability and PharmacokineticsPharmacodynamics of PAC-14028 After Oral Administration in Healthy Male Volunteers
Status:
COMPLETED
Status Verified Date:
2014-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
1 Primary Objective
To evaluate safety and tolerability of single and multiple oral dosing of PAC-14028 in healthy male volunteers
2 Secondary Objective
To evaluate pharmacokinetics and pharmacodynamics of single and multiple oral dosing of PAC-14028 in healthy male volunteers
To evaluate safety and tolerability of single and multiple oral dosing of PAC-14028 in healthy male volunteers
2 Secondary Objective
To evaluate pharmacokinetics and pharmacodynamics of single and multiple oral dosing of PAC-14028 in healthy male volunteers
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None